This course has no confirmed dates in the future. Subscribe to be notified when it is offered.
About the course
Prescription drugs are a major contributor to the expense of your health plan. It is imperative you understand the broad forces at work and ways to mitigate costs to your plan in order to succeed.
Prescription Drug Costs, Usage and Outcomes: Practical Insights from Research is a one-day program presented by Harvard Medical School faculty and other industry innovators that will use research-based data to separate the truth from fiction on prescription drug topics.
Attend this unique opportunity to reveal strategies to effectively work with pharmacy benefit managers (PBMs) and benefits consultants, ways to utilize your plan design to promote drug adherence and discuss what factors your plan can or cannot have on influencing the market.
Topics for this one-day program are:
- Fundamentals of Drug Pricing
- Assessing Drug Value
- Utilization/Demand Management in Specialty Drug Plan Design
- Value-Based Plan Design: Evaluating Models for Drug Purchasing and Reimbursement
- Academic Detailing: Motiviation and Organization
- Academic Detailing: Experience and Outcomes
Limited seats are being offered at this program to foster discussion and allow for optimal access to Harvard Medical School faculty and researchers. Sessions will utilize small group discussion, case study review and faculty-led lecture.
Who should attend
This program is structured to fit the educational needs of senior-level group health benefit decision makers.
Trust the experts
Aaron Kesselheim MD JD MPH is an Associate Professor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women’s Hospital. Within the Division, Aaron created and leads the Program On ...
With nearly 20 years of experience in the business and policy of health care, Sarah leads the strategic planning and operations of ICER as Executive Vice President and Chief Operating Officer. In that role, she is responsible for overseeing ICER’s public programs, communications, operations, and...
As Corporate Vice-President and CMO for Specialty at CVSHealth, Dr. Singh is responsible for the Company’s specialty client & clinical strategy, product innovation, analytics and clinical program management. In this role, he leads a multifaceted team of clinicians and analysts, manages the c...
In his role as Senior Vice President & Chief Medical Officer at Harvard Pilgrim Health Care, Dr. Sherman is responsible for Harvard Pilgrim’s medical trend management, network medical management, medical informatics, wellness and health promotion initiatives, care and disease management servi...
Jerry Avorn, MD, is a Professor of Medicine at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women’s Hospital. An internist, geriatrician, and drug epidemiologist, he studies the intended and adverse eff...
Michael Fischer, MD, MS, is an Associate Professor of Medicine at Harvard Medical School and an Associate Physician in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. His research interests include prescription drug reimbursement policy, electronic pres...